Transposagen Creates a Rat Model of the Human Immune System
LEXINGTON, Ky. , Aug. 6 /PRNewswire/ -- Transposagen Biopharmaceuticals, Inc. based in Lexington, KY announced today that its scientists and collaborators from the Medical College of Wisconsin have created and characterized the world's first rat model of severe combined immunodefi...
International Milk Genomics & Human Health Symposium Speaker Program Announced
The speaker program for the 6th International Symposium on Milk Genomics & Human
Health has been released. The three-day event will be held September 28-29, 2009 at the Mercure Paris Porte de Versailles Expo Hotel in Paris, France. The agenda for the 6th annual meeting includes presentations ...
First genetically engineered malaria vaccine to enter human trials
Walter and Eliza Hall Institute scientists have created a weakened strain of the malaria parasite that will be used as a live vaccine against the disease. The vaccine, developed in collaboration with researchers from the US, Japan and Canada, will be trialled in humans from early next year.
OMT announces a breakthrough in the development of a novel human antibody platform
Palo Alto, CA: July 23, 2009 Open Monoclonal Technology, Inc. (OMT), in collaboration with Sangamo BioSciences, Inc. (NASDAQ, SGMO), Sigma-Aldrich Corporation (NASDAQ: SIAL), The Medical College of Wisconsin, and INSERM, today announced the creation of the first targeted knockout rats as detaile...
Sinovac Initiates Dosing in Human Clinical Trial of Panflu for Pandemic Influenza A (H1N1)
BEIJING, July 22 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE AMEX:
SVA ), a leading provider of vaccines in China, today announced that it has
initiated dosing today in its clinical trial of various Panflu vaccine
candidates for pandemic influenza A (H1N1). Results are expected in Septem...
PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin
NES-ZIONA, Israel, June 30 /PRNewswire-FirstCall/ -- PROLOR Biotech, Inc. (OTC Bulletin Board: PBTH), formerly Modigene Inc., today announced that the U. S. Patent and Trademark Office (PTO) has issued two new patents for the company's long-acting CTP-enhanced human
growth hormone (hGH-CTP) and hu...
Fruit fly steps in to fight human disease
"By putting mutant genes from human
patients into fruit flies, we've created the first ever fly model for this kind of neuromuscular disease," says Albena Jordanova. "Now we have the opportunity to unravel the molecular mechanism behind Charcot-Marie-Tooth, as well as to start looking for substanc...
Assessment of safety and efficacy of human embryonic stem cell therapy
Worcester, MA June 11, 2009 (EurekAlert)--Advanced Cell Technology, Inc. (OTC:ACTC.PK) and its collaborators at OHSU reported today the long-term safety and efficacy of human
embryonic stem cell (hESC)-derived retinal pigment epithelium (RPE) produced under manufacturing conditions suitable for hu...
Printing New Organs: Foundation Funds Medical Technology That Replicates Human Tissue
SPRINGFIELD, Va., June 9 /PRNewswire/ -- Methuselah Foundation has identified Organovo, Inc. as a leader in the extraordinary science of bio-printing. The US Department of Health and Human
Services predicts: "Within 20 years regenerative medicine will be the standard of care for replacing all tis...
New MIT radio chip mimics human ear
CAMBRIDGE, Mass.--MIT engineers have built a fast, ultra-broadband, low-power radio chip, modeled on the human
inner ear, that could enable wireless devices capable of receiving cell phone, Internet, radio and television signals.
Rahul Sarpeshkar, associate professor of electrical engineering ...
deCODE Study Shows Complex Interplay of the Human Biological Clock With Height, Weight and Disease
Reykjavik, ICELAND, May 17 /PRNewswire-FirstCall/ -- In a paper published
today in the online edition of Nature Genetics, scientists from deCODE
genetics (Nasdaq: DCGN ) and academic colleagues from Iceland, Denmark and the
Netherlands present the discovery of single letter variations in the ...
STEMCELL Technologies Introduces a New Animal Component-Free, Serum-Free Medium for Culturing Human Mesenchymal Stem Cells
STEMCELL Technologies, Inc. today announced the release of MesenCult®-ACF Medium , the first defined, animal component-free (ACF) and serum-free medium for culturing human
mesenchymal stem cells (MSCs).
Vancouver, B.C. (PRWEB) April 28, 2009 -- STEMCELL Technol...
CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease
Technology also has potential to fight cancer, rheumatoid arthritis, as well as enhance the effectiveness of vaccines
VIENNA, Va., April 27 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE Amex: CVM ) announced today the presentation of data at the 11th annual National Foundation of Infe...
ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Mesenchymal Cells
ATHENS, Ga., March 27 /PRNewswire/ -- ArunA Biomedical, Inc., announced today that it will make its CELL-EZ(TM) brand hMC(TM) human
mesenchymal progenitor cells commercially available to the research community in mid 2009. Derived from pluripotent human
embryonic stem cells, ArunA's hMC lines wil...
ArunA Biomedical, Inc. Announces Alliance with Neuromics for Distribution of Normal Human Neural Cells
ATHENS, Ga., March 23 /PRNewswire/ -- ArunA Biomedical, Inc., announced today an agreement with Neuromics, Inc. of Edina, MN, giving Neuromics the right to non-exclusively market and sell the ArunA hN2(TM) Human
Neural Cells and Neural Culture Medium to support applications in neurological resea...
IEEE Celebrates Its 125th Anniversary Presenting Emerging, World Changing Technologies During Its 'Embracing Human Technology Interactions' Media Event
Event Features Panel Discussion on Technologies That Will Change the Way Humans Interact with Machines, the World and Each Other
PISCATAWAY, N.J., March 10 /PRNewswire/ -- IEEE, the world's largest technical professional society, today spotlighted seven technologies it believes will have worl...
China Biologic Products' High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan
TAIAN CITY, Shandong, China, Feb. 13 /PRNewswire-Asia-FirstCall/ -- China
Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the
"Company"), one of the leading plasma-based pharmaceutical companies in the
People's Republic of China ("PRC"), today announced that one of its ...
Victhom Human Bionics Receives CE Mark for the Neurostep(TM) System, the World's First Fully Implantable Closed-Loop Neuromodulation Therapy for Treatment of Foot Drop
QUEBEC CITY, Feb. 3 /PRNewswire-FirstCall/ - Victhom Human
Bionics Inc., "Victhom" (TSX:VHB), announced today that its Neurobionix division has obtained CE Mark approval for its Neurostep(TM) System, the first ever approval for a closed-loop system (CLS) used on peripheral nerves. CE Mark represen...
ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Neural Cells
ATHENS, Ga., Jan. 30 /PRNewswire/ -- ArunA Biomedical, Inc., announced today that it will make its hN2(TM) cells commercially available to the research community in early 2009. The cells, derived from NIH registered human
embryonic cell lines, are offered as a normal, consistent population of neu...
Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone
-hGH-CTP Development Program Has Been Approved For Second-Year Funding Through a Special Grant From the Israeli Office of the Chief Scientist-
NES-ZIONA, Israel, Jan. 27 /PRNewswire-FirstCall/ -- Modigene Inc. (OTC Bulletin Board: MODG) today reported that its Israeli-based R&D subsidiary...
Victhom Human Bionics Neurobionix Division receives ISO 13485:2003 Certification for its Design Control System
QUEBEC, Jan. 23 /PRNewswire-FirstCall/ - Victhom Human
Bionics Inc., "Victhom" (TSX: VHB), announced today that its Neurobionix division has achieved ISO 13485:2003 certification for its Quality System Design Control. This certification, an internationally recognized management system standard dev...
MultiVu Video Feed: Geron Receives FDA Clearance to Begin World's First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
Geron to Study GRNOPC1 in Patients with Acute Spinal Cord Injury
Geron Corporation (Nasdaq: GERN ) announced that the U.S. Food and Drug
Administration (FDA) has granted clearance of the company's Investigational
New Drug (IND) application for the clinical trial of GRNOPC1 in patient...
Rules-Based Medicine, Inc. Launches Human Kidney Damage Biomarker Panel
Complements the RBM Rat Kidney Panel developed in conjunction with the Critical Path Initiative
AUSTIN, Texas, Jan. 15 /PRNewswire/ -- Rules-Based Medicine, Inc. (RBM), the world's leading multiplexed biomarker testing laboratory, today announced the launch of its Human
Kidney Multi-Analyte P...
HemoGenix(R), Inc Announces Implementation of ORF Genetics Human Growth Factors and Cytokines in All Human HALO(R) Assay Kits and Contract Research Services
COLORADO SPRINGS, Colo. and REYKJAVIK, Iceland, Dec. 3 /PRNewswire/ --
HemoGenix(R) and ORF Genetics announce the collaboration and implementation of
biorisk-free, green-source growth factors and cytokines for use in all HALO(R)
Assay Kits and HALO(R) Contract Research Services where the response ...
ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies
PARIS, November 28 /PRNewswire-FirstCall/ -- ExonHit Therapeutics S.A.
(Alternext: ALEHT), a drug and diagnostic discovery company, announces today
the availability of its new SpliceArray(TM) for use in studying mouse models
disease. These SpliceArray(TM) products help our clients acceler...
Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervical Cancer
MEXICO CITY, Mexico, November 19 /PRNewswire-FirstCall/ -- In a campaign
to significantly reduce the most common cancer affecting Mexican women, the
Mexican Public Health Agency (Secretaria de Salud or SSA) has announced it is
launching the first phase of a program that will offer testing for huma...
Clinical Data Show Long-Acting Human Growth Hormone ARX201 is Safe and Well Tolerated
Long-Acting hGH Analogue Requires Only Weekly Dosing
SAN DIEGO, Nov. 13 /PRNewswire/ -- Ambrx Inc. today announced Phase
I/II clinical trial data demonstrating that ARX201, the company's
growth hormone (hGH) analogue developed in collaboration
with Merck Serono, normalized ...
Interleukin Genetics to Present New Findings on Osteoporosis at the 58th Annual Meeting of the American Society of Human Genetics
Genetic Variations Identify Predisposition and Risks of Progression of
Vertebral Fracture in US-Caucasian Women
WALTHAM, Mass., Nov. 11 /PRNewswire-FirstCall/ -- Interleukin Genetics,
Inc. (Amex: ILI ), announced today that Nazneen Aziz, Ph.D., the company's
Vice President of Research and D...
Data to Be Presented at 58th Annual Meeting of The American Society of Human Genetics
NOVATO, Calif., Nov. 6 /PRNewswire-FirstCall/ -- BioMarin
Pharmaceutical Inc. (Nasdaq: BMRN ) announced today that data from clinical
studies of Kuvan(R) (sapropterin dihydrochloride), Naglazyme(R)
(galsulfase) and enzyme replacement therapies for MPS IVA (Morquio
Syndrome) and Pompe disease ...
Ambrx to Present Phase I/II Clinical Data for Optimized, Long Acting Human Growth Hormone Analogue
SAN DIEGO, Nov. 5 /PRNewswire/ -- Ambrx Inc. today announced the
scheduled presentation of data from a Phase I/II clinical trial of ARX201,
the company's long-acting human
growth hormone (hGH) analogue developed in
collaboration with Merck Serono, at the International Congress of
Complete Genomics Chooses Isilon IQ to Power World's First Complete Human Genome Sequencing Service
Pioneer in DNA Sequencing Deploys Clustered Storage to Help Redefine the Economics of Large-Scale Sequencing
SEATTLE, Nov. 3 /PRNewswire-FirstCall/ -- Isilon(R) Systems (Nasdaq:
ISLN), the leader in clustered storage, today announced that Complete
Genomics, the world's first p...
The human brain minimizes energy expenditure and integrates gravity in to the action plan
When reaching for an object, the brain prepares neural commands sent to the target muscles to minimize energy expenditure, according to a study published in PLoS Computational Biology by neuroscientists and mathematicians from the INSERM and ENSTA.
How the human
brain organizes and controls ...
EntreMed's ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
ROCKVILLE, Md., Oct. 23 /PRNewswire-FirstCall/ -- EntreMed, Inc.
(Nasdaq: ENMD ), a clinical-stage pharmaceutical company developing
therapeutics for the treatment of cancer and inflammatory diseases, today
announced the presentation of preclinical data for its Aurora
A/angiogenesis kinase in...
Pioneer(R) Surgical Technology Announces First Human Implants of New nanOss(TM)-Cervical Fusion Device
First Synthetic Nanotechnology Implant Offers Promising Patient Solutions
MARQUETTE, Mich., Oct. 16 /PRNewswire/ -- Pioneer Surgical Technology,
Inc., a leader in innovative medical devices, announced today the
implantation of its new biologic inter-body spacer. The
Complete Genomics Launches, Becomes World's First Large-Scale Human Genome Sequencing Company
Company to sequence 1,000 human
genomes in 2009 for $5,000 each
MOUNTAIN VIEW, Calif., Oct. 6 /PRNewswire/ -- Complete Genomics Inc., a
genome sequencing company, today announced its
formal launch as the world's first provider of large-scale human
Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics
CARLSBAD, Calif., Oct. 3 /PRNewswire-FirstCall/ -- Isis
Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced today that its
majority-owned subsidiary, Ibis Biosciences, Inc. (Ibis), was awarded
government grants and contracts from the United States Department of
Agriculture (USDA), National Instit...
Pigs bred with cystic fibrosis provide model to mimic human disease
COLUMBIA, Mo. Cystic Fibrosis (CF) continues to be a lethal disease for humans despite the identification of the problematic gene two decades ago. Many humans born with CF the most common genetic disease in Caucasians - often die because of a lung disease developed later. Scientists have been un...
China Biologic Receives SFDA Approval for Clinical Trial of Human Coagulation Factor VIII
TAIAN CITY, Shandong, China, Sept. 17 /Xinhua-PRNewswire-FirstCall/ --
China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic"
or the "Company"), one of the leading plasma-based pharmaceutical companies
in the People's Republic of China ("PRC"), today announced that the Comp...
Simcere Pharmaceutical Group Announces Two Senior Promotions and Appointment of New Vice President of Human Resources
NANJING, China, Sept. 12 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical
Group (NYSE: SCR ), a leading manufacturer and supplier of branded generic
pharmaceuticals and manufacturer of the patented anti-cancer biotech
product Endu in China, today announces the promotions of Mr. Jindong Zhou
Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
Appoints Stephen Ross Senior Vice President of Commercial Operations
and James Briggs Senior Vice President of Human
CLINTON, N.J., Aug. 25 /PRNewswire/ -- Ikaria Holdings, Inc., a fully
integrated critical care biotherapeutics company, announced today the
addition of two key execu...